ACPT-I, with the CAS number 194918-76-8, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in cancer therapy. It is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. ACPT-I acts as a selective inhibitor, targeting specific pathways involved in tumor growth and proliferation. Its mechanism of action typically involves interference with cellular signaling processes, making it a candidate for further research in oncology. The compound's solubility, stability, and pharmacokinetic properties are crucial for its efficacy and safety profile in therapeutic applications. Additionally, ongoing studies aim to elucidate its full range of biological effects and potential side effects, which are essential for understanding its viability as a treatment option. As with many experimental compounds, detailed characterization through various analytical techniques is necessary to fully understand its properties and potential uses in clinical settings.

ACPT-I

194918-76-8: ACPT-I, with the CAS number 194918-76-8, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in cancer therapy. It is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity. ACPT-I acts as a selective inhibitor, targeting specific pathways involved in tumor growth and proliferation. Its mechanism of action typically involves interference with cellular signaling processes, making it a candidate for further research in oncology. The compound's solubility, stability, and pharmacokinetic properties are crucial for its efficacy and safety profile in therapeutic applications. Additionally, ongoing studies aim to elucidate its full range of biological effects and potential side effects, which are essential for understanding its viability as a treatment option. As with many experimental compounds, detailed characterization through various analytical techniques is necessary to fully understand its properties and potential uses in clinical settings.

<p>Agonist for group III mGlu receptors</p>

CAS 194918-76-8

ACPT-I

ACPT-I

Ref: TM-T22549